economic analysis

经济分析
  • 文章类型: Journal Article
    为了有效利用木质生物质,丰度密度低,有必要开发一种发电系统,即使在小于2兆瓦的小容量下也可以高效率地转换它。对于发电,使用小型往复式发动机是合理的。在自然吸气火花点火往复式发动机(SIRE)的情况下,一个循环中吸入的气体量几乎完全由排量决定。SIRE的热效率通常随着功率的增加而增加。因此,为了提高热效率,使燃料的低热值(LHV)更高,以增加自然吸气SIRE的功率是有效的。在本文中,使用三种方法来增加生物合成气的LHV:1)降低生物合成气的氮气密度(升级生物合成气),2)向生物合成气中添加氢气,和3)向生物合成气中添加甲烷。使用这些燃料,1)大功率的条件,和2)每个条件的假定成本,通过实验和估计进行评估。结果表明,升级后的生物合成气,通过富氧空气气化获得,拥有最高的功率和最佳的成本效益。
    In order to effectively utilize woody biomass, which has a low abundance density, it is necessary to develop a power generation system that can convert it with high efficiency even with a small capacity as less than 2 MW. For electricity generation, it is reasonable to use a small reciprocating engine. In the case of a naturally aspirated spark ignition reciprocating engine (SIRE), the amount of aspirated gas in one cycle is determined almost entirely by the displacement. The thermal efficiency of the SIRE generally increases with the power. Therefore, to improve the thermal efficiency, it is effective to make the low heating value (LHV) of the fuel higher to increase the power of the naturally aspirated SIRE. In this paper, three methods are used to increase the LHV of the bio-syngas: 1) reducing the nitrogen density of the bio-syngas (upgrade bio-syngas), 2) adding hydrogen to the bio-syngas, and 3) adding methane to the bio-syngas. Using these fuels, 1) the conditions for high power, and 2) the costs assumed for each condition, are evaluated through experiments and estimates. The results showed that the upgrade bio-syngas, obtained by gasification with oxygen-enriched air, had the highest power and the best cost-effectiveness.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    优化光伏(PV)存储系统的运行对于满足公园的负载需求,同时最大程度地减少缩减并提高经济效率至关重要。本文提出了一种基于主从博弈模型的光伏储能系统多场景协同优化策略。补偿负载转移,并参与频率调节(FR)市场,从而优化园区光伏储能系统的整体运营策略。上层目标是公园经营者利润最大化,而较低级别的目标是最大限度地降低用户的供电成本。案例研究表明,该策略可以显着提高25.8%的园区经营者的经济效益,用户用电支出减少5.27%,并通过负载响应机制降低削减,从而促进光伏储能园区的开发建设。
    Optimizing the operation of photovoltaic (PV) storage systems is crucial for meeting the load demands of parks while minimizing curtailment and enhancing economic efficiency. This paper proposes a multi-scenario collaborative optimization strategy for PV storage systems based on a master-slave game model. Three types of energy storage system (ESS) application scenarios are designed to comprehensively stabilize PV fluctuations, compensate for load transfers, and participate in the frequency regulation (FR) market, thereby optimizing the overall operational strategy of PV storage systems in parks. The upper-level objective is to maximize the park operators\' profit, while the lower-level objective is to minimize the user\'s power supply costs. Case studies demonstrate that this strategy can significantly increase the economic benefits for park operators by 25.8%, reduce user electricity expenditures by 5.27%, and lower curtailment through a load response mechanism, thereby promoting the development and construction of PV storage parks.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    3D打印血管模型可以提高腹部游离皮瓣乳房重建的皮瓣收获效率,减少手术室的使用时间。然而,迄今为止,还没有就这种情况下的模型使用进行经济分析。因此,这项研究探讨了用于腹部游离皮瓣乳房重建的模型成本效益权衡。
    3D-printed vascular models can enhance flap harvesting efficiency in abdominal free flap breast reconstruction, reducing the use of operating room time. However, no economic analyses with respect to model use in this context have been conducted to date. As such, this study examines model cost-benefit tradeoffs for use in abdominal free flap breast reconstruction.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:分析影响美国公众对青少年驾照要求变更偏好的因素。
    方法:我们采用了离散选择实验(DCE),来自国家意见研究中心的AmeriSpeak小组的808名参与者,以评估许可系统的两个现有要素(道路测试和中间许可期)和新功能(在中间许可期使用远程信息处理进行驾驶员监控)的偏好。多项式和混合logit模型用于估计偏好权重,边际替代率和每个属性的相对重要性。
    结果:在完成所有DCE选择任务的730名受访者中,我们发现了对青少年驾驶执照要求变化的有力支持,偏好因个人特征而异。受访者对青少年驾驶执照政策的变更表示了很高的基线支持。他们赞成测试,优先考虑简单的测试,并反对延长驾驶员监控和延长中间执照期限。基线偏好权重表现出显著的异质性,强调公众偏好的多样性。边际替代率表明,在延长的中间许可期内,倾向于延长驾驶员监控。简单测试的价值是硬测试的2.85倍。最有影响力的属性是中间许可期限的长度和测试要求,前者的重要性是前者的两倍。
    结论:我们的研究发现,对青少年驾驶执照要求的改革提供了有力的支持。有利于更容易的道路驾驶测试,而不是长期的中级执照和驾驶员监控。公众对许可制度的偏好需要与更广泛的政策目标相平衡,包括优化流动性和最大限度地提高安全性。
    OBJECTIVE: To analyse factors influencing the American public\'s preferences for changes to teenage driver licensing requirements.
    METHODS: We employed a discrete choice experiment (DCE) with 808 participants from National Opinion Research Center\'s AmeriSpeak panel to assess preferences for two existing elements (on-road testing and intermediate licensure period) and a new feature (driver monitoring with telematics during the intermediate licensure period) of licensing system. Multinomial and mixed logit models were used to estimate preference weights, marginal rates of substitution and the relative importance of each attribute.
    RESULTS: Among 730 respondents who completed all DCE choice tasks, we found robust support for changes to teenage driver licensing requirements, with preferences varying by individual characteristics. Respondents expressed a high baseline support for changes to teen driving licensure policies. They favoured testing, prioritising easy tests and opposed prolonged driver monitoring and extended intermediate licensure periods. Baseline preference weights exhibited substantial heterogeneity, emphasising the diversity of public preferences. The marginal rates of substitution revealed a preference for extended driver monitoring over an extended intermediate licensure period. An easy test was valued at 2.85 times more than a hard one. The most influential attributes were the length of intermediate licence period and testing requirements, with the former twice as important.
    CONCLUSIONS: Our study found robust support for reforms to teenage driver licensing requirements, favouring easier on-road driving tests over an extended period of intermediate licensure and driver monitoring. Public preferences for licensing systems need to be balanced with the broader policy objectives including optimising mobility and maximising safety.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    孟加拉国拥有广泛的太阳能发电可能性;然而,在太阳能行业充分发挥潜力的主要障碍是能源部门预算不足。因此,为每个特定场景确定最经济和有效的太阳能模块配置已成为一个关键的必要性。这项研究提供了四个不同的太阳能模块的全面技术经济分析和环境影响评估:单面,双面,双轴太阳能跟踪器,和季节性倾斜太阳能模块,在南Sakucia联盟的一个开放区域,Bhola区,在孟加拉国的西南部。通过整合发电能力,财务指标,和环境效益,这项研究提供了一个整体评估框架,以确保孟加拉国可持续太阳能解决方案的最佳经济绩效和最小的不利环境影响。利用PV*SOL,PVsyst,和SystemAdvisorModel(SAM)软件,这项研究评估了发电能力和经济可行性。尽管双轴太阳能跟踪器显示出最高的平均发电量(149,070.3kWh/年),与其他配置相比,较高的初始成本使其在财务上不太可行。财务指标显示,季节性倾斜配置是最具成本效益的,最低的电力成本(LCOE)为0.0452美元/千瓦时,最高的净现值(NPV)为52,887.70美元。此外,它的折扣回收期(DPBP)最短,为12.69年,有利的内部收益率(IRR)为9.460%,盈利能力指数(PI)为1.459,表明投资回报强劲。这些发现强调了在评估孟加拉国南部太阳能组件配置时考虑发电能力和财务指标的重要性。为决策者提供有价值的参考。此外,细致的环境影响评估有助于选择对环境不利影响最小的配置。
    Bangladesh is blessed with an extensive range of solar energy generation possibilities; however, the primary impediment to attaining its full potential in the solar energy industry is the inadequate budget in the energy sector. As a result, determining the most economical and efficient solar module configuration for each specific scenario has become a critical necessity. This study offers a comprehensive techno-economic analysis and environmental impact assessment of four distinct solar modules: monofacial, bifacial, dual-axis solar tracker, and seasonal tilt solar module, in an open area of South Sakucia Union, Bhola district, in the southwest part of Bangladesh. By integrating energy-generation capabilities, financial metrics, and environmental benefits, this research provides a holistic evaluation framework to ensure optimal economic performance and minimal adverse environmental effects for sustainable solar solutions in Bangladesh. Utilizing PV*SOL, PVsyst, and System Advisor Model (SAM) software, this study assesses energy-generation capabilities and economic viability. Despite the dual-axis solar tracker exhibiting the highest average energy generation (149,070.3 kWh/year), its higher initial cost renders it less financially viable compared to other configurations. Financial metrics reveal that the seasonal tilt configuration is the most cost-efficient, with the lowest Levelized Cost of Electricity (LCOE) at $0.0452/kWh and the highest Net Present Value (NPV) of $52,887.70. Additionally, it has the shortest Discounted Payback Period (DPBP) at 12.69 years, a favorable Internal Rate of Return (IRR) of 9.460 %, and a Profitability Index (PI) of 1.459, indicating robust returns on investment. These findings emphasize the importance of considering both energy-generation capabilities and financial metrics when evaluating solar module configurations in the southern part of Bangladesh, serving as a valuable reference for policymakers. Moreover, meticulous environmental impact assessments assist in choosing configurations with minimal adverse effects on the environment.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    帕金森氏病是一种导致逐渐失去协调性和运动问题的脑部疾病。在英国,大约有145,500人患有帕金森病。左旋多巴是在早期阶段管理运动症状的最处方治疗。应每6-12个月由专科医生监测患者的疾病进展和不良反应的治疗。可穿戴设备可以通过直接监测患者的运动迟缓,提供一种新的管理方法。运动障碍,震颤等症状。它们旨在与临床判断一起使用。
    确定用于监测帕金森病的五种设备的临床和成本效益:个人动力学图,Kinesia360,KinesiaU,PDMonitor和STAT-ON。
    我们对五种设备的所有证据进行了系统评价,结果包括:诊断准确性,对决策的影响,临床结果,患者和临床医生的意见和经济结果。我们检索了截至2022年2月的MEDLINE和其他12个数据库/试验登记处。评估偏倚风险。叙事综合被用来总结所有确定的证据,因为证据不足以进行荟萃分析.其中一项试验提供了个人水平的数据,重新分析。开发了一个从头决策分析模型,以估算个人运动图和Kinesia360在5年时间范围内与英国NHS护理标准相比的成本效益。基本情况分析考虑了两种替代监测策略:一次性使用和设备的常规使用。
    57项个人动力学图谱研究,15个STAT-ON,包括Kinesia360的3个,KinesiaU的1个和PDMonitor的1个。有一些证据表明,个人运动图可以准确地测量运动迟缓和运动障碍,导致一些患者的治疗改变,使用统一帕金森病评定量表测量时,临床结果可能有所改善。STAT-ON的证据表明它可能对诊断症状有价值,但目前尚无证据表明其临床影响。Kinesia360,KinesiaU和PDMonitor的证据不足以就其在临床实践中的价值得出任何结论。与一次性和常规使用的护理标准相比,PersonalKinetiGraph的基本案例结果导致每质量调整生命年增加67,856英镑和57,877英镑的成本效益比,分别,个人动力学图对统一帕金森病评定量表III和IV域的有益影响。与一次性和常规使用的护理标准相比,Kinesia360的增量成本效益比结果为每获得质量调整生命年38,828英镑和67,203英镑,分别。
    证据的范围有限,质量通常很低。对于所有设备,除了个人动力学图,该技术的临床影响几乎没有证据。
    个人动力学图可以合理地在实践中用于监测患者症状并在需要时修改治疗。关于STAT-ON的证据太少了,Kinesia360,KinesiaU或PDMonitor确信它们在临床上有用。远程监测的成本效益似乎在很大程度上不利,在一系列替代假设中,每质量调整生命年的增量成本效益比超过30,000英镑。成本效益的主要驱动因素是患者症状改善的持久性。
    本研究注册为PROSPEROCRD42022308597。
    该奖项由美国国家卫生与护理研究所(NIHR)证据综合计划(NIHR奖项参考:NIHR135437)资助,并在《卫生技术评估》中全文发表;卷。28号30.有关更多奖项信息,请参阅NIHR资助和奖励网站。
    帕金森氏病是一种导致协调性丧失和运动问题的脑部疾病。左旋多巴是治疗早期疾病的最佳处方。患者应每6-12个月由专科医生就诊,以评估其治疗需求。可穿戴设备(如智能手表)可以通过直接监测患者的疾病症状,包括震颤和运动迟缓(运动迟缓)来帮助管理。或治疗的副作用,如不自主运动(运动障碍)。这项评估考虑了五种可穿戴设备的临床和经济价值:PersonalKinetiGraph,STAT-ON,Kinesia360,KinesiaU和PDMonitor。我们搜索了医学数据库,找到了这五种设备的所有研究。我们评估了这些研究的质量并回顾了它们的结果。我们发现了77项有关该设备的研究。有一些证据表明,个人运动图可以准确地测量运动迟缓和运动障碍,导致一些患者的治疗改变,和症状的可能改善。STAT-ON的证据表明它可能对诊断症状有价值,但目前尚无证据证明其临床价值。Kinesia360,KinesiaU和PDMonitor没有足够的证据得出任何结论。进行了经济分析,以调查使用这些技术中的任何一种是否在经济上可行。经济分析发现,相对于在NHS中实施远程监控设备的额外成本,远程监控设备产生的生活质量收益很小。因此,与目前的护理标准相比,没有一种远程监护设备物有所值.
    UNASSIGNED: Parkinson\'s disease is a brain condition causing a progressive loss of co ordination and movement problems. Around 145,500 people have Parkinson\'s disease in the United Kingdom. Levodopa is the most prescribed treatment for managing motor symptoms in the early stages. Patients should be monitored by a specialist every 6-12 months for disease progression and treatment of adverse effects. Wearable devices may provide a novel approach to management by directly monitoring patients for bradykinesia, dyskinesia, tremor and other symptoms. They are intended to be used alongside clinical judgement.
    UNASSIGNED: To determine the clinical and cost-effectiveness of five devices for monitoring Parkinson\'s disease: Personal KinetiGraph, Kinesia 360, KinesiaU, PDMonitor and STAT-ON.
    UNASSIGNED: We performed systematic reviews of all evidence on the five devices, outcomes included: diagnostic accuracy, impact on decision-making, clinical outcomes, patient and clinician opinions and economic outcomes. We searched MEDLINE and 12 other databases/trial registries to February 2022. Risk of bias was assessed. Narrative synthesis was used to summarise all identified evidence, as the evidence was insufficient for meta-analysis. One included trial provided individual-level data, which was re-analysed. A de novo decision-analytic model was developed to estimate the cost-effectiveness of Personal KinetiGraph and Kinesia 360 compared to standard of care in the UK NHS over a 5-year time horizon. The base-case analysis considered two alternative monitoring strategies: one-time use and routine use of the device.
    UNASSIGNED: Fifty-seven studies of Personal KinetiGraph, 15 of STAT-ON, 3 of Kinesia 360, 1 of KinesiaU and 1 of PDMonitor were included. There was some evidence to suggest that Personal KinetiGraph can accurately measure bradykinesia and dyskinesia, leading to treatment modification in some patients, and a possible improvement in clinical outcomes when measured using the Unified Parkinson\'s Disease Rating Scale. The evidence for STAT-ON suggested it may be of value for diagnosing symptoms, but there is currently no evidence on its clinical impact. The evidence for Kinesia 360, KinesiaU and PDMonitor is insufficient to draw any conclusions on their value in clinical practice. The base-case results for Personal KinetiGraph compared to standard of care for one-time and routine use resulted in incremental cost-effectiveness ratios of £67,856 and £57,877 per quality-adjusted life-year gained, respectively, with a beneficial impact of the Personal KinetiGraph on Unified Parkinson\'s Disease Rating Scale domains III and IV. The incremental cost-effectiveness ratio results for Kinesia 360 compared to standard of care for one-time and routine use were £38,828 and £67,203 per quality-adjusted life-year gained, respectively.
    UNASSIGNED: The evidence was limited in extent and often low quality. For all devices, except Personal KinetiGraph, there was little to no evidence on the clinical impact of the technology.
    UNASSIGNED: Personal KinetiGraph could reasonably be used in practice to monitor patient symptoms and modify treatment where required. There is too little evidence on STAT-ON, Kinesia 360, KinesiaU or PDMonitor to be confident that they are clinically useful. The cost-effectiveness of remote monitoring appears to be largely unfavourable with incremental cost-effectiveness ratios in excess of £30,000 per quality-adjusted life-year across a range of alternative assumptions. The main driver of cost-effectiveness was the durability of improvements in patient symptoms.
    UNASSIGNED: This study is registered as PROSPERO CRD42022308597.
    UNASSIGNED: This award was funded by the National Institute for Health and Care Research (NIHR) Evidence Synthesis programme (NIHR award ref: NIHR135437) and is published in full in Health Technology Assessment; Vol. 28, No. 30. See the NIHR Funding and Awards website for further award information.
    Parkinson’s disease is a brain condition causing loss of co-ordination and movement problems. Levodopa is the most prescribed treatment for early disease. Patients should be seen by a specialist every 6–12 months to assess their treatment needs. Wearable devices (like smart watches) may aid management by directly monitoring patients for disease symptoms including tremor and slowness of movement (bradykinesia), or side effects of treatment like involuntary movement (dyskinesia). This assessment considered the clinical and economic value of five wearable devices: Personal KinetiGraph, STAT-ON, Kinesia 360, KinesiaU and PDMonitor. We searched medical databases to find all studies of the five devices. We assessed the quality of these studies and reviewed their results. We found 77 studies of the devices. There was some evidence to suggest that Personal KinetiGraph can accurately measure bradykinesia and dyskinesia, leading to treatment modification in some patients, and a possible improvement in symptoms. The evidence for STAT-ON suggested it may be of value for diagnosing symptoms, but there is currently no evidence on its clinical value. There was insufficient evidence for Kinesia 360, KinesiaU and PDMonitor to draw any conclusions. An economic analysis was conducted to investigate whether using any of these technologies is economically viable. The economic analysis found that the quality-of-life benefits generated by remote monitoring devices were small relative to the additional costs of implementing them in the NHS. As such, none of the remote monitoring devices were good value for money when compared with the current standard of care.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    椰子树幼苗的生产是生产过程中的重要环节,因为它大大影响了成年植物的生产性能,而获得幼苗的方式直接反映了增加的成本。为了降低成本,引入生物刺激剂可以被认为是一种可行和可持续的技术。本研究旨在评价应用蜡样芽孢杆菌促进巴西矮生椰子幼苗生长和降低成本的效果。这项研究有两个阶段,第一个是在巴西帕拉州的商业托儿所进行的实验。设计是完全随机的,有两种处理:用水控制(100%矿物质施肥)和蜡状芽孢杆菌接种(50%矿物质施肥),每个重复10次。生物特征参数和幼苗质量进行了评估。在第二阶段,将刺激幼苗的产量与商业幼苗的产量进行了比较,并确定了有效运营成本(COE)和总运营成本(TOC)。B.cereus的生物刺激促进椰子树幼苗的生长,提高幼苗质量,减少了托儿所的时间。此外,生产成本降低了10%。因此,微生物技术是巴西绿矮椰子幼苗生产的积极策略。使用蜡状芽孢杆菌可以保证以更低的成本获得高性能的幼苗。这些结果可能有利于获得高产的成年植物。
    在线版本包含补充材料,可在10.1007/s12088-023-01163-9获得。
    The production of coconut tree seedlings is an important step in the production process, as it substantially affects the productive performance of the adult plant, and the way of obtaining seedlings directly reflects the added costs. To minimize costs, the introduction of biostimulants can be considered a viable and sustainable technology. This study aimed to evaluate the effects of applying Bacillus cereus in promoting growth and reducing the costs of producing Brazilgreen dwarf coconut seedlings. The study has two stages, the first was an experiment carried out in a commercial nursery in the state of Pará-Brazil. The design was completely randomized, with two treatments: control with water (100% mineral fertilization) and B. cereus inoculation (50% mineral fertilization), with 10 replicates each. Biometric parameters and the quality of seedlings were evaluated. In the second stage, the production of stimulated seedlings was compared to that of commercial seedlings, and the effective operating cost (COE) and the total operating cost (TOC) were determined. Biostimulation with B. cereus promotes the growth of coconut tree seedlings, increases seedling quality, and reduces nursery time. In addition, the cost of production is reduced by 10%. Thus, microbial technology is a positive strategy for the production of Brazilian green dwarf coconut seedlings. Using B. cereus can guarantee obtaining seedlings with high performance and at a lower cost. These results may favor obtaining adult plants with high productivity.
    UNASSIGNED: The online version contains supplementary material available at 10.1007/s12088-023-01163-9.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    这项工作评估了经济条件变化对浮动光伏的成本和可行性的影响,一种新颖的解决方案,其中模块安装在水上或水上。对多个欧洲国家的关键经济标准进行了敏感性分析,首先生成特定国家的基线情景,然后在输入参数中引入系统变化。结果表明,资本支出和电价,近年来两者都经历了重大变化,对净现值和内部收益率的影响最大。同样,资本支出和折现率是影响电力成本水平的最大因素。总的来说,本研究通过确定经济变量与浮动光伏发电的可行性之间的相关性,为文献做出了贡献。研究结果可用于评估潜在政府政策和支持机制的有效性,并评估该技术在不同的国家和国际经济条件下的可行性。
    This work evaluates the effects of economic conditions\' variations on the costs and viability of floating photovoltaics, a novel solution where modules are installed on or above water. A sensitivity analysis of key economic criteria is conducted across multiple European countries, first generating country-specific baseline scenarios and then introducing systematic variations into the input parameters. The results show that capital expenditure and electricity prices, which have both experienced significant variations in recent years, have the largest influence on the net present value and the internal rate of return. Similarly, capital expenditure and discount rate are found to be the most influencing factors for the levelized cost of electricity. Overall, this study contributes to the literature by identifying the correlations between the economic variables and the viability of floating photovoltaics. The findings can be used to assess the effectiveness of potential government policies and support mechanisms and to evaluate the viability of this technology under varying national and international economic conditions.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    本研究调查了使用棕榈仁壳(PKS)合成活性炭用于二氧化碳吸附,油棕工业的副产品。吸附剂合成涉及简单的两步碳化方法。首先,PKS被氧化钾(KOH)激活,然后用氧化镁(MgO)官能化。表面分析显示,与未处理的PKS(435m2/g)相比,KOH活化的PKS产生1086m2/g的高比表面积。然而,MgO的浸渍由于MgO堵塞孔隙而导致表面积减小。热重分析(TGA)表明,在500°C下,基于PKS的吸附剂表现出小于30%的最小重量损失。表明它们适合高温应用。CO2吸附实验表明,在25°C和5巴下,与PKS-AC(149.63mg/g)相比,PKS-AC-MgO实现了更高的吸附容量155.35mg/g。通过Sips和Langmuir等温线很好地拟合了PKS-AC-MgO的吸附行为,表明非均相和均相吸附的组合,并表明MgO和CO2之间的化学反应。热力学分析表明,PKS-AC-MgO捕获CO2的自发和热力学有利的过程,焓为负变化(-0.21kJ/mol),熵正变化(2.44kJ/mol),吉布斯自由能的负变化(-729.61J/mol,-790.79J/mol,和-851.98J/mol)在整个测试温度下。经济评估显示,PKS-AC-MgO的成本比目前商业活性炭的市场价格低21%,表明了其工业应用的潜力。环境评估表明,通过利用PKS-AC-MgO,温室气体排放量(381.9tCO2)显着减少,强调其环境效益。总之,使用由PKS生产并用MgO官能化的活性炭显示出吸收CO2的巨大潜力。这符合循环经济和可持续发展的理念。
    This study investigates the synthesize of activated carbon for carbon dioxide adsorption using palm kernel shell (PKS), a by-product of oil palm industry. The adsorbent synthesis involved a simple two-step carbonization method. Firstly, PKS was activated with potassium oxide (KOH), followed by functionalization with magnesium oxide (MgO). Surface analysis revealed that KOH activated PKS has resulted in a high specific surface area of 1086 m2/g compared to untreated PKS (435 m2/g). However, impregnation of MgO resulted in the reduction of surface area due to blockage of pores by MgO. Thermogravimetric analysis (TGA) demonstrated that PKS-based adsorbents exhibited minimal weight loss of less than 30% up to 500 °C, indicating their suitability for high-temperature applications. CO2 adsorption experiments revealed that PKS-AC-MgO has achieved a higher adsorption capacity of 155.35 mg/g compared to PKS-AC (149.63 mg/g) at 25 °C and 5 bars. The adsorption behaviour of PKS-AC-MgO was well fitted by both the Sips and Langmuir isotherms, suggesting a combination of both heterogeneous and homogeneous adsorption and indicating a chemical reaction between MgO and CO2. Thermodynamic analysis indicated a spontaneous and thermodynamically favourable process for CO2 capture by PKS-AC-MgO, with negative change in enthalpy (- 0.21 kJ/mol), positive change in entropy (2.44 kJ/mol), and negative change in Gibbs free energy (- 729.61 J/mol, - 790.79 J/mol, and - 851.98 J/mol) across tested temperature. Economic assessment revealed that the cost of PKS-AC-MgO is 21% lower than the current market price of commercial activated carbon, indicating its potential for industrial application. Environmental assessment shows a significant reduction in greenhouse gas emissions (381.9 tCO2) through the utilization of PKS-AC-MgO, underscoring its environmental benefits. In summary, the use of activated carbon produced from PKS and functionalised with MgO shows great potential for absorbing CO2. This aligns with the ideas of a circular economy and sustainable development.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    在SVR(单心室重建)试验中,右心室至肺动脉分流术(RVPAS)接受者的1年生存率优于接受改良Blalock-Taussig-Thomas分流术(MBTTS)的接受者,但不是在随后的后续行动中。成本分析是评估价值和发病率的一种权宜之计。
    本研究的目的是评估RVPAS和MBTTS之间累积住院费用的差异。
    将来自SVR的临床数据和来自儿科健康信息系统数据库的成本合并。在RVPAS和MBTTS之间的1年、3年和5年连续比较了累积住院费用和每日生存费用。使用多变量模型探讨了患者水平因素与成本之间的潜在关联。
    总共,研究了来自15个站点中9个的303名参与者(占SVR队列的55%)(占MBTTS的48%)。MBTTS在1年观察到的总费用($701,260±442,081)低于RVPAS($804,062±615,068),差异无统计学意义(P=0.10)。3年和5年的总费用也没有显着差异(P=0.21和0.32)。同样,两组患者在1,3和5年时的每日生存成本均无显著差异(均P>0.05).在对无移植幸存者的分析中,RVPAS的总费用和每日生存成本在1年时较高(两者均P=0.05),但在3年和5年时不高(均P>0.05).在多变量模型中,主动脉闭锁和早产与随访期间每日生存成本的增加相关(P<0.05).
    MBTTS和RVPAS之间的总成本没有显着差异。纵向成本的巨大程度强调了努力改善这一弱势群体成果的重要性。
    UNASSIGNED: In the SVR (Single Ventricle Reconstruction) Trial, 1-year survival in recipients of right ventricle to pulmonary artery shunts (RVPAS) was superior to that in those receiving modified Blalock-Taussig-Thomas shunts (MBTTS), but not in subsequent follow-up. Cost analysis is an expedient means of evaluating value and morbidity.
    UNASSIGNED: The purpose of this study was to evaluate differences in cumulative hospital costs between RVPAS and MBTTS.
    UNASSIGNED: Clinical data from SVR and costs from Pediatric Health Information Systems database were combined. Cumulative hospital costs and cost-per-day-alive were compared serially at 1, 3, and 5 years between RVPAS and MBTTS. Potential associations between patient-level factors and cost were explored with multivariable models.
    UNASSIGNED: In total, 303 participants (55% of the SVR cohort) from 9 of 15 sites were studied (48% MBTTS). Observed total costs at 1 year were lower for MBTTS ($701,260 ± 442,081) than those for RVPAS ($804,062 ± 615,068), a difference that was not statistically significant (P = 0.10). Total costs were also not significantly different at 3 and 5 years (P = 0.21 and 0.32). Similarly, cost-per-day-alive did not differ significantly for either group at 1, 3, and 5 years (all P > 0.05). In analyses of transplant-free survivors, total costs and cost-per-day-alive were higher for RVPAS at 1 year (P = 0.05 for both) but not at 3 and 5 years (P > 0.05 for all). In multivariable models, aortic atresia and prematurity were associated with increased cost-per-day-alive across follow-up (P < 0.05).
    UNASSIGNED: Total costs do not differ significantly between MBTTS and RVPAS. The magnitude of longitudinal costs underscores the importance of efforts to improve outcomes in this vulnerable population.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号